Breaking News Instant updates and real-time market news.

MOR

MorphoSys

$28.18 /

-0.03 (-0.11%)

, JNJ

Johnson & Johnson

$148.18 /

+0.695 (+0.47%)

16:32
12/02/20
12/02
16:32
12/02/20
16:32

MorphoSys says Janssen reports European Commission approval for Tremfya

MorphoSys (MOR) announced that its licensee Janssen (JNJ) reported the European Commission's approval for the use of Tremfya in the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug therapy. Developed and marketed by Janssen, Tremfya is the first approved fully human monoclonal antibody that selectively binds to the p19 subunit of IL-23-an important driver of the progression of inflammatory diseases and inhibits its interaction with the IL-23 receptor. It was generated utilizing MorphoSys' proprietary HuCAL antibody technology and became the first drug based on MorphoSys' antibody technology to receive regulatory approval for the treatment of plaque psoriasis in 2017. Tremfya is currently approved in 76 countries for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy2, and in Brazil, Canada, Ecuador, Japan, Taiwan, and the U.S. for the treatment of adult patients with active PsA. "As a new, first-in-its-class treatment option for patients with psoriatic arthritis, Tremfya provides much-needed treatment opportunities to improve the lives of patients suffering from this debilitating disease," said Dr. Malte Peters, Chief Research and Development Officer at MorphoSys. "We are very pleased and extremely proud that Tremfya has been approved by the European Commission for the treatment of adult patients with active psoriatic arthritis in the European Union."

MOR

MorphoSys

$28.18 /

-0.03 (-0.11%)

JNJ

Johnson & Johnson

$148.18 /

+0.695 (+0.47%)

  • 05

    Dec

  • 15

    Dec

  • 26

    Jan

MOR MorphoSys
$28.18 /

-0.03 (-0.11%)

11/25/20
Fly Intel: Top five analyst initiations
11/25/20 Morgan Stanley
MorphoSys initiated with an Equal Weight at Morgan Stanley
11/18/20 Goldman Sachs
MorphoSys initiated with a Neutral at Goldman Sachs
11/13/20 Barclays
MorphoSys price target lowered to EUR 90 from EUR 110 at Barclays
JNJ Johnson & Johnson
$148.18 /

+0.695 (+0.47%)

11/24/20 Raymond James
Intuitive Surgical not surprised by J&J robot features, says Raymond James
11/23/20 SVB Leerink
AstraZeneca vaccine 'will never be licensed in the U.S.,' says SVB Leerink
11/12/20 Chardan
Immunovant price target raised to $60 from $45 at Chardan
11/10/20 Piper Sandler
Aligos Therapeutics initiated with an Overweight at Piper Sandler

TODAY'S FREE FLY STORIES

Hot Stocks
Kiromic BioPharma announces completion, certification of Houston facility » 05:32
01/20/21
01/20
05:32
01/20/21
05:32
KRBP

Kiromic BioPharma

$8.70 /

+0.31 (+3.69%)

Kiromic BioPharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRBP Kiromic BioPharma
$8.70 /

+0.31 (+3.69%)

  • 16
    Oct
KRBP Kiromic BioPharma
$8.70 /

+0.31 (+3.69%)

Downgrade
Gritstone Oncology downgraded to Underperform from Outperform at Baird » 05:31
01/20/21
01/20
05:31
01/20/21
05:31
GRTS

Gritstone Oncology

$22.47 /

+16.07 (+251.09%)

Baird analyst Madhu Kumar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRTS Gritstone Oncology
$22.47 /

+16.07 (+251.09%)

GRTS Gritstone Oncology
$22.47 /

+16.07 (+251.09%)

07/14/20 BTIG
Gritstone Oncology price target lowered to $17 from $31 at BTIG
GRTS Gritstone Oncology
$22.47 /

+16.07 (+251.09%)

Upgrade
Signature Aviation upgraded to Hold from Sell at Berenberg » 05:30
01/20/21
01/20
05:30
01/20/21
05:30
BBAVY

Signature Aviation

$0.00 /

+ (+0.00%)

Berenberg analyst Eoghan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBAVY Signature Aviation
$0.00 /

+ (+0.00%)

11/12/20 Berenberg
Signature Aviation price target raised to 205 GBp from 165 GBp at Berenberg
09/09/20 JPMorgan
Signature Aviation price target lowered to 245 GBp from 267 GBp at JPMorgan
09/09/20 Barclays
Signature Aviation price target raised to 265 GBp from 250 GBp at Barclays
08/26/20 JPMorgan
Signature Aviation downgraded to Neutral from Overweight at JPMorgan
Downgrade
Ambu downgraded to Hold from Buy at DNB Markets » 05:30
01/20/21
01/20
05:30
01/20/21
05:30
AMBBY

Ambu

$0.00 /

+ (+0.00%)

DNB Markets analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMBBY Ambu
$0.00 /

+ (+0.00%)

11/12/20 JPMorgan
Ambu price target lowered to DKK 184 from DKK 192 at JPMorgan
10/15/20 JPMorgan
Ambu price target raised to DKK 192 from DKK 190 at JPMorgan
10/12/20 JPMorgan
JPMorgan backs Neutral on Ambu after chairman resignation
08/28/20 JPMorgan
Ambu price target lowered to DKK 190 from DKK 219 at JPMorgan
Downgrade
GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse » 05:29
01/20/21
01/20
05:29
01/20/21
05:29
GSK

GlaxoSmithKline

$38.53 /

+0.07 (+0.18%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

01/15/21 Deutsche Bank
GlaxoSmithKline initiated with a Hold at Deutsche Bank
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
12/08/20 JPMorgan
GlaxoSmithKline price target lowered to 1,500 GBp from 1,650 GBp at JPMorgan
12/03/20
Fly Intel: Top five analyst downgrades
GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

Hot Stocks
Weis Markets CFO Scott Frost to retire, Michael Lockard to succeed » 05:28
01/20/21
01/20
05:28
01/20/21
05:28
WMK

Weis Markets

$47.52 /

-0.97 (-2.00%)

Weis Markets announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse » 05:28
01/20/21
01/20
05:28
01/20/21
05:28
NVO

Novo Nordisk

$73.01 /

+0.99 (+1.37%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

01/15/21 Deutsche Bank
Novo Nordisk initiated with a Buy at Deutsche Bank
11/16/20 Piper Sandler
Piper says 'underwhelming' data from Novo Nordisk a 'big win' for Intercept
11/12/20 JPMorgan
Novo Nordisk price target lowered to DKK 470 from DKK 480 at JPMorgan
11/06/20 Morgan Stanley
Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley
NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

NVO Novo Nordisk
$73.01 /

+0.99 (+1.37%)

Downgrade
Schweiter downgraded to Add from Buy at Baader Helvea » 05:27
01/20/21
01/20
05:27
01/20/21
05:27
SCWTF

Schweiter

$0.00 /

+ (+0.00%)

Baader Helvea analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCWTF Schweiter
$0.00 /

+ (+0.00%)

05/26/20 UBS
Schweiter price target lowered to CHF 1,080 from CHF 1,200 at UBS
Upgrade
Boeing upgraded to Hold from Sell at Berenberg » 05:27
01/20/21
01/20
05:27
01/20/21
05:27
BA

Boeing

$210.66 /

+6.41 (+3.14%)

Berenberg analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$210.66 /

+6.41 (+3.14%)

BA Boeing
$210.66 /

+6.41 (+3.14%)

01/04/21
Fly Intel: Top five analyst downgrades
01/04/21 Baird
Boeing elevated to Fresh Pick at Baird
01/04/21 Bernstein
Bernstein downgrades Boeing to Underperform on worsening 787 outlook
01/04/21 Bernstein
Boeing downgraded to Underperform from Market Perform at Bernstein
BA Boeing
$210.66 /

+6.41 (+3.14%)

BA Boeing
$210.66 /

+6.41 (+3.14%)

BA Boeing
$210.66 /

+6.41 (+3.14%)

BA Boeing
$210.66 /

+6.41 (+3.14%)

Downgrade
Gerdau downgraded to Hold from Buy at HSBC » 05:24
01/20/21
01/20
05:24
01/20/21
05:24
GGB

Gerdau

$4.76 /

-0.12 (-2.46%)

HSBC analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GGB Gerdau
$4.76 /

-0.12 (-2.46%)

01/12/21 Goldman Sachs
Gerdau downgraded to Neutral from Buy at Goldman Sachs
12/15/20 Morgan Stanley
Gerdau upgraded to Overweight from Equal Weight at Morgan Stanley
10/07/20 Bradesco BBI
Gerdau upgraded to Outperform from Neutral at Bradesco BBI
10/07/20 Bradesco BBI
Gerdau upgraded to Outperform from Neutral at Bradesco BBI
Downgrade
Grupo Financiero Banorte downgraded to Hold from Buy at HSBC » 05:22
01/20/21
01/20
05:22
01/20/21
05:22
GBOOF

Grupo Financiero Banorte

$0.00 /

+ (+0.00%)

HSBC analyst Carlos…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBOOF Grupo Financiero Banorte
$0.00 /

+ (+0.00%)

10/27/20 Citi
Grupo Financiero Banorte downgraded to Neutral from Buy at Citi
10/13/20 Credit Suisse
Banorte upgraded to Outperform from Underperform at Credit Suisse
06/17/20 Goldman Sachs
Grupo Financiero Banorte initiated with a Buy at Goldman Sachs
05/14/20 Credit Suisse
Banorte downgraded to Underperform from Neutral at Credit Suisse
Hot Stocks
Alcon launches PRECISION1 contact lens in the U.S. » 05:22
01/20/21
01/20
05:22
01/20/21
05:22
ALC

Alcon

$72.68 /

+2.57 (+3.67%)

Alcon announced the U.S.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALC Alcon
$72.68 /

+2.57 (+3.67%)

ALC Alcon
$72.68 /

+2.57 (+3.67%)

01/07/21 KeyBanc
Veeva initiated with an Overweight at KeyBanc
11/19/20 Berenberg
Alcon price target raised to CHF 69 from CHF 62 at Berenberg
11/16/20 JPMorgan
Alcon price target raised to CHF 57 from CHF 55 at JPMorgan
11/12/20 Jefferies
Alcon price target raised to $78 from $71 at Jefferies
ALC Alcon
$72.68 /

+2.57 (+3.67%)

ALC Alcon
$72.68 /

+2.57 (+3.67%)

ALC Alcon
$72.68 /

+2.57 (+3.67%)

Upgrade
CK Infrastructure upgraded to Buy from Hold at HSBC » 05:22
01/20/21
01/20
05:22
01/20/21
05:22
CKISY

CK Infrastructure

$0.00 /

+ (+0.00%)

HSBC analyst Evan Li…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Banco Santander upgraded to Buy from Hold at HSBC » 05:21
01/20/21
01/20
05:21
01/20/21
05:21
SAN

Banco Santander

$3.29 /

+0.005 (+0.15%)

HSBC analyst Domenico…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

01/19/21 Barclays
Banco Santander price target raised to EUR 3.10 from EUR 2.90 at Barclays
01/15/21 Morgan Stanley
Banco Santander price target raised to EUR 3.50 from EUR 3.30 at Morgan Stanley
01/11/21 Deutsche Bank
Banco Santander price target raised to EUR 2.85 from EUR 2.80 at Deutsche Bank
01/11/21 UBS
Banco Santander upgraded to Buy from Neutral at UBS
SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

SAN Banco Santander
$3.29 /

+0.005 (+0.15%)

Downgrade
Arjo downgraded to Sell from Hold at Nordea » 05:20
01/20/21
01/20
05:20
01/20/21
05:20
ARRJF

Arjo

$0.00 /

+ (+0.00%)

Nordea analyst Sten…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Amryt receives NICE approval for Myalepta reimbursement in England, Wales » 05:19
01/20/21
01/20
05:19
01/20/21
05:19
AMYT

Amryt Pharma

$13.49 /

+ (+0.00%)

Amryt announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMYT Amryt Pharma
$13.49 /

+ (+0.00%)

AMYT Amryt Pharma
$13.49 /

+ (+0.00%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
Upgrade
Daimler AG upgraded to Buy from Hold at HSBC » 05:19
01/20/21
01/20
05:19
01/20/21
05:19
DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

HSBC analyst Henning…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

01/14/21 R.F. Lafferty
Luminar initiated with a Buy at R.F. Lafferty
01/08/21 Deutsche Bank
Daimler AG named short-term investment idea at Deutsche Bank
01/07/21 Deutsche Bank
Daimler AG price target raised to EUR 70 from EUR 60 at Deutsche Bank
11/27/20 Exane BNP Paribas
Exane double upgrades Daimler on Mercedes electric car potential
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

Hot Stocks
Calliditas Therapeutics to provide data from Part A of NefIgArd study » 05:17
01/20/21
01/20
05:17
01/20/21
05:17
CALT

Calliditas Therapeutics

$31.90 /

+1.35 (+4.42%)

Calliditas Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CALT Calliditas Therapeutics
$31.90 /

+1.35 (+4.42%)

CALT Calliditas Therapeutics
$31.90 /

+1.35 (+4.42%)

07/01/20 Citi
Calliditas Therapeutics initiated with a Buy at Citi
06/30/20 Jefferies
Calliditas Therapeutics initiated with a Buy at Jefferies
06/30/20 Stifel
Calliditas Therapeutics initiated with a Buy at Stifel
  • 05
    Jun
Downgrade
Elkem ASA downgraded to Hold from Buy at DNB Markets » 05:17
01/20/21
01/20
05:17
01/20/21
05:17
ELKEF

Elkem ASA

$0.00 /

+ (+0.00%)

DNB Markets analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELKEF Elkem ASA
$0.00 /

+ (+0.00%)

06/24/20 Citi
Elkem ASA downgraded to Sell from Neutral at Citi
03/30/20 Morgan Stanley
Elkem ASA price target lowered to NOK 17 from NOK 21 at Morgan Stanley
Upgrade
Cairn Energy upgraded to Add from Hold at Peel Hunt » 05:16
01/20/21
01/20
05:16
01/20/21
05:16
CRNCY

Cairn Energy

$0.00 /

+ (+0.00%)

Peel Hunt analyst Werner…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRNCY Cairn Energy
$0.00 /

+ (+0.00%)

01/12/21 Morgan Stanley
Cairn Energy price target raised to 250 GBp from 248 GBp at Morgan Stanley
01/11/21 RBC Capital
Cairn Energy price target raised to 300 GBp from 150 GBp at RBC Capital
01/11/21 Barclays
Cairn Energy price target raised to 315 GBp from 235 GBp at Barclays
12/24/20 AlphaValue
Cairn Energy upgraded to Add from Sell at AlphaValue
Upgrade
Trainline upgraded to Buy from Hold at Panmure Gordon » 05:15
01/20/21
01/20
05:15
01/20/21
05:15
TNLIY

Trainline

$0.00 /

+ (+0.00%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TNLIY Trainline
$0.00 /

+ (+0.00%)

01/19/21 Deutsche Bank
Trainline price target lowered to 512 GBp from 527 GBp at Deutsche Bank
12/10/20 JPMorgan
Trainline price target raised to 486 GBp from 430 GBp at JPMorgan
12/03/20 Stifel
Trainline initiated with a Buy at Stifel
10/19/20 Deutsche Bank
Trainline initiated with a Buy at Deutsche Bank
Downgrade
Crown Resorts downgraded to Neutral from Outperform at Credit Suisse » 05:13
01/20/21
01/20
05:13
01/20/21
05:13
CWLDF

Crown Resorts

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Netflix upgraded to Overweight from Equal Weight at Wells Fargo » 05:11
01/20/21
01/20
05:11
01/20/21
05:11
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

05:01 Today Piper Sandler
Netflix price target raised to $652 from $643 at Piper Sandler
04:52 Today Pivotal Research
Netflix price target raised to $750 from $660 at Pivotal Research
04:41 Today UBS
Netflix upgraded to Buy from Neutral at UBS
01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

Downgrade
Bloom Energy downgraded to Neutral from Outperform at Credit Suisse » 05:06
01/20/21
01/20
05:06
01/20/21
05:06
BE

Bloom Energy

$39.89 /

+3.41 (+9.35%)

Credit Suisse analyst…

Credit Suisse analyst Michael Weinstein downgraded Bloom Energy to Neutral from Outperform with a price target of $32, up from $27. The stock closed Tuesday up 9% to $39.93. The analyst increased the price target to reflect higher 2024 and 2025 growth rates due to a two year federal solar tax credit extension and potentially favorable zero-carbon policy under President Biden. Weinstein, however, downgrades Bloom due to valuation.

ShowHide Related Items >><<
BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

01/14/21 JPMorgan
Bloom Energy price target raised to $35 from $26 at JPMorgan
01/12/21 Morgan Stanley
Morgan Stanley downgrades 2020 top performer Bloom Energy to Equal Weight
01/12/21 Morgan Stanley
Bloom Energy downgraded to Equal Weight from Overweight at Morgan Stanley
12/21/20 Morgan Stanley
Bloom Energy price target raised to $32 from $21 at Morgan Stanley
BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

  • 15
    Oct
  • 02
    Oct
BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

BE Bloom Energy
$39.89 /

+3.41 (+9.35%)

Upgrade
Megaport upgraded to Buy from Neutral at Goldman Sachs » 05:03
01/20/21
01/20
05:03
01/20/21
05:03
MGPPF

Megaport

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGPPF Megaport
$0.00 /

+ (+0.00%)

MGPPF Megaport
$0.00 /

+ (+0.00%)

08/06/20 Canaccord
Megaport upgraded to Buy from Hold at Canaccord

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.